Skip to main content

Animations

MJFF Publications

8881 - 8890 of 9038 Results
Title
Year
  • Year
  • 2021
  • 2024
  • 2024
  • 2024
  • 2025
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Remote smartphone monitoring of Parkinson’s disease and individual response to therapy
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41587-021-00974-9
    Citation Count: 143
  • Summary Details
    OPEN
    Title: Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-024-03270-6
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Longitudinal correlation of cerebrospinal fluid GFAP and the progression of cognition decline in different clinical subtypes of Parkinson's disease
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/cts.70111
    Citation Count: 3
  • Summary Details
    OPEN
    Title: A data-driven model of disability progression in progressive multiple sclerosis
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae434
    Citation Count: 4
  • Summary Details
    OPEN
    Title: N2GNet tracks gait performance from subthalamic neural signals in Parkinson’s disease
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-024-01364-6
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Excessive Daytime Sleepiness as a Risk Factor for Impulse Control Disorders in Parkinson’s Disease
    Journal Name: Neuropsychiatric Disease and Treatment
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.2147/ndt.s485339
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Enhanced detection of distinct honeycomb-structured neuronal SMARCC2 cytobodies in Parkinson’s Disease via Cyclic Heat-Induced Epitope Retrieval (CHIER)
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0315183
    Citation Count: 0
  • Summary Details
    OPEN
    Title: African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41594-024-01423-2
    Citation Count: 16
  • Summary Details
    OPEN
    Title: TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cell.2024.05.030
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Pharmacological targeting of dopamine D1 or D2 receptors evokes a rapid‐onset parkinsonian motor phenotype in mice
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16622
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.